PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.\', \'Carol Yu Centre for Infection, State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.\', \'Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518000, China.\', \'Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 54910.3390/v14030549
?:doi
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 35336956
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
?:title
  • A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all